IRIS
TOMBOLINI, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 727
EU - Europa 425
AS - Asia 258
SA - Sud America 87
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 1.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 716
IE - Irlanda 169
SG - Singapore 118
CN - Cina 84
BR - Brasile 83
DE - Germania 64
SE - Svezia 50
IT - Italia 31
HK - Hong Kong 28
UA - Ucraina 24
RU - Federazione Russa 22
GB - Regno Unito 17
TR - Turchia 14
BE - Belgio 13
FI - Finlandia 12
FR - Francia 10
CA - Canada 8
CZ - Repubblica Ceca 6
AU - Australia 3
EU - Europa 3
IQ - Iraq 3
ES - Italia 2
NL - Olanda 2
PK - Pakistan 2
UY - Uruguay 2
AT - Austria 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
IL - Israele 1
IN - India 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
TN - Tunisia 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.506
Salva come PNG Salva come JPEG
Città #
Chandler 192
Dublin 169
Jacksonville 95
Singapore 87
Ann Arbor 45
Santa Clara 40
Ashburn 35
Boardman 32
Hong Kong 28
New York 28
Wilmington 21
Lawrence 20
Princeton 20
Bremen 15
Brussels 13
Munich 13
Nanjing 12
Beijing 11
Helsinki 11
Izmir 10
São Paulo 10
Woodbridge 8
Brno 6
Changsha 6
L'aquila 6
Los Angeles 6
San Mateo 6
Shenyang 6
Council Bluffs 5
Des Moines 5
Falls Church 5
Grafing 5
Kunming 5
Rome 5
Berlin 4
Falkenstein 4
Milan 4
Mountain View 4
Nanchang 4
Shanghai 4
Toronto 4
Washington 4
Belo Horizonte 3
Guangzhou 3
Norwalk 3
Seattle 3
Curitiba 2
Dearborn 2
Frankfurt am Main 2
Hanover 2
Hebei 2
Lanzhou 2
Madrid 2
Montevideo 2
Ottawa 2
Redwood City 2
Salvador 2
Santo André 2
Tappahannock 2
Tianjin 2
Afonso Cláudio 1
Alaşehir 1
Almaty 1
Amman 1
Amsterdam 1
Anshan 1
Anápolis 1
Araçatuba 1
Baghdad 1
Baoding 1
Beauharnois 1
Bellante 1
Belém 1
Bogotá 1
Brest 1
Cabreúva 1
Cabrobó 1
Caicó 1
Campina Grande 1
Campina Grande do Sul 1
Campo Grande 1
Campo Largo 1
Campos Sales 1
Canberra 1
Cape Town 1
Caruaru 1
Cascavel 1
Caxias do Sul 1
Changchun 1
Chicago 1
Chieti 1
Chongqing 1
Chuzhou 1
Colombo 1
Concórdia 1
Congonhas 1
Cormeilles-en-Parisis 1
Cotia 1
Cuiabá 1
Dallas 1
Totale 1.093
Salva come PNG Salva come JPEG
Nome #
Moderate hypofractionation in patients with low-risk prostate cancer: Long-term outcomes 138
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 136
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 104
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 103
New approaches in glioblastoma multiforme: The potential role of immune-check point inhibitors 98
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 84
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 78
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 77
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 74
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 72
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 69
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 65
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 63
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 61
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 59
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 56
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 51
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 47
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 46
Sinonasal Undifferentiated Carcinoma in a Patient Previously Treated for an Intestinal-Type Adenocarcinoma: Metachronous Neoplasms or Recurrence of a Different Tumor Type? 45
Targeted molecular therapy in glioblastoma 12
Resilience in Radiotherapy Services During the COVID-19 Emergency: Collaboration Between the Regional Radiation Oncology Departments of Lazio, Abruzzo and Molise 7
Totale 1.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 0 0 0 14 8 3 13
2020/2021129 3 12 1 16 14 4 21 1 19 8 25 5
2021/2022144 7 1 29 9 3 9 7 7 18 6 8 40
2022/2023491 30 42 6 80 33 52 0 24 200 6 12 6
2023/2024138 6 14 11 5 6 60 9 2 0 5 6 14
2024/2025428 18 10 30 60 89 69 82 48 22 0 0 0
Totale 1.545